Global equities opened August firmer after the US chose to delay potential strikes on Iran. Markets pushed higher despite the geopolitical uncertainty, with broad-based gains across most indices and little evidence of any reversal in the recent shift away from technology. The FTSE 100\u2019s move towards 11,000 remained stalled, largely due to AstraZeneca, even as underlying market breadth improved.<\/p>\n\n
Technology led much of the advance, although Apple fell in post-earnings trade after acting as a relative haven over the past month. At the same time, an intra-sector rotation lifted Amazon to a fresh record high, supporting the wider \u201cMagnificent 7\u201d complex even though some members continue to claw back earlier losses. The move comes into what is typically a more volatile August, leaving the durability of the rebound in question.<\/p>\n\n
We are seeing markets jump on a temporary relief rally as geopolitical tensions ease, but history suggests we should tread carefully. August is historically one of the most volatile periods of the year, with the S&P 500 averaging a 0.15% decline over the last few decades. Derivative traders should prepare for this seasonal lull by focusing on short-term plays rather than committing to heavy bullish positions.<\/p>\n\n
While Amazon’s recent record highs provide a spark, Apple’s post-earnings slide shows that even the biggest tech giants are vulnerable to sudden profit-taking. We recommend using options strategies like bear call spreads on tech laggards to capitalize on this ongoing rotation out of mega-caps. This allows us to benefit from premium decay while keeping a tight lid on our risk during sudden market reversals.<\/p>\n\n
The CBOE Volatility Index (VIX) typically climbs by an average of 10% to 15% during August as trading volumes thin out and chop increases. To exploit this expected rise in volatility, we should look at buying protective puts or setting up long straddles on major index exchange-traded funds. These strategies will help us profit from sharp swings in either direction without needing to guess the market’s exact path.<\/p>\n\n
Looking abroad, the FTSE 100 remains stalled near key resistance levels, dragged down by heavyweights like AstraZeneca. We can target this stagnation by selling iron condors on international index options to collect premium from range-bound foreign markets. This approach keeps our capital active and diversified as we navigate a historically choppy month of global trading.<\/p>\n\n\n\n